High-dose etoposide: from phase I to a component of curative therapy.
Wolff
Steven N
SN
Meharry Medical College, Nashville, TN, USA.
Hainsworth
John D
JD
Greco
F Anthony
FA
D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage* / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy
D000972:Antineoplastic Agents, Phytogenic; D005047:Etoposide